Manchester, UK - 18 July 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life sciences company focused on skin health, announces that it has received provisional ethics approval for its human study scheduled to start later this year....
18th July, 2018 Read MoreCEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening https://youtu.be/pol8NsE_of4...
22nd June, 2018 Read MoreManchester, UK - 29 May 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, announces its collaboration as industrial partner in a grant awarded by the Biotechnology and Biological Sciences Research Council (BBSRC) to The University of Mancheste...
29th May, 2018 Read MoreSkinBioTherapeutics to present on 20 June 2018 at the Shares and AJ Bell Spotlight Evening in London. Shareholders and potential investors can register now for free at: http://www.sharesmagazine.co.uk/events...
29th May, 2018 Read MoreSkinBioTherapeutics is featured in the latest edition of the Health Europa Quarterly publication...
16th May, 2018 Read MoreManchester, UK - 14 May 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces a new patent filing. The patent application is to cover the use of SkinBiotix® for increasing filaggrin levels in skin....
14th May, 2018 Read More